M J Smyth Selected Research

M J Smyth Research Topics

Disease

24	Neoplasms (Cancer) 01/2017 - 01/2000
5	Neoplasm Metastasis (Metastasis) 03/2001 - 02/2000
4	Lymphoma (Lymphomas) 05/2007 - 09/2000
3	Infections 02/2015 - 07/2001
2	Sarcoma (Soft Tissue Sarcoma) 01/2014 - 04/2001
2	Multiple Myeloma 05/2010 - 01/2010
2	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2001 - 01/2001
2	Fibrosarcoma 04/2001 - 01/2001
2	Carcinoma (Carcinomatosis) 01/2001 - 04/2000
1	Melanoma (Melanoma, Malignant) 01/2017
1	Weight Loss (Weight Reduction) 01/2016
1	Ulcerative Colitis 01/2016
1	Inflammation (Inflammations) 01/2016
1	Hypersensitivity (Allergy) 02/2015
1	Triple Negative Breast Neoplasms 08/2014
1	Breast Neoplasms (Breast Cancer) 08/2014
1	Carcinogenesis 09/2010
1	Adenocarcinoma 09/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2007
1	Hematologic Neoplasms (Hematological Malignancy) 05/2007
1	Immune System Diseases (Immune Disorders) 07/2001
1	Ectromelia (Phocomelia) 01/2001
1	Necrosis 08/2000
1	Virus Diseases (Viral Diseases) 06/2000
1	Starvation 04/2000
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2000

Drug/Important Bio-Agent (IBA)

9	PerforinIBA 08/2001 - 04/2000
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007 - 01/2000
6	LigandsIBA 05/2007 - 01/2001
4	Granzymes (Granzyme)IBA 01/2016 - 06/2000
4	Interferon-gamma (Interferon, gamma)IBA 05/2010 - 01/2001
4	Interleukin-12 (IL 12)IBA 04/2001 - 02/2000
4	MethylcholanthreneIBA 04/2001 - 02/2000
3	InterleukinsIBA 09/2010 - 02/2000
3	InterferonsIBA 09/2010 - 03/2001
3	AntigensIBA 05/2010 - 05/2007
3	Proteins (Proteins, Gene)FDA Link 05/2007 - 01/2000
3	CaspasesIBA 09/2004 - 04/2000
2	CytokinesIBA 02/2015 - 01/2001
2	Lewis Y antigenIBA 09/2010 - 05/2010
2	Death Domain ReceptorsIBA 05/2007 - 05/2007
2	Monoclonal AntibodiesIBA 12/2001 - 01/2001
2	Fas Ligand Protein (Fas Ligand)IBA 01/2001 - 04/2000
2	CarcinogensIBA 01/2001 - 02/2000
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2000 - 01/2000
2	Pharmaceutical PreparationsIBA 06/2000 - 01/2000
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2017
1	Dextran SulfateIBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 02/2015
1	Trastuzumab (Herceptin)FDA Link 08/2014
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 03/2014
1	Immunoglobulins (Immunoglobulin)IBA 01/2014
1	Immunoglobulin A (IgA)IBA 01/2014
1	Fc Receptors (Fc Receptor)IBA 01/2014
1	AntibodiesIBA 01/2014
1	Immunoglobulin G (IgG)IBA 01/2014
1	AnthracyclinesIBA 01/2014
1	Therapeutic UsesIBA 01/2014
1	CalreticulinIBA 01/2014
1	AutoantigensIBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 09/2010
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2010
1	InflammasomesIBA 09/2010
1	Adenosine (Adenocard)FDA LinkGeneric 09/2010
1	CarbohydratesIBA 05/2010
1	Immunomodulating AgentsIBA 01/2010
1	TNF-Related Apoptosis-Inducing LigandIBA 05/2007
1	Biological ProductsIBA 05/2007
1	Histone Deacetylase InhibitorsIBA 05/2007
1	Vorinostat FDA Link 05/2007
1	Cytochromes c (Cytochrome c)IBA 09/2004
1	Vincristine (Oncovin)FDA LinkGeneric 09/2004
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2001
1	alpha-galactosylceramideIBA 03/2001
1	Interleukin-4 (Interleukin 4)IBA 03/2001
1	IgE Receptors (Fc epsilon RI)IBA 01/2001
1	EndotoxinsIBA 08/2000
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2000

Therapy/Procedure

5	Therapeutics 01/2017 - 09/2000
2	Immunotherapy 05/2010 - 04/2001
1	Drug Therapy (Chemotherapy) 01/2014
1	Ligation 01/2001